Allogeneic Stem Cell Transplantation for Advanced Neuroblastoma Using MHC Mismatched Related Donors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Neuroblastoma
Related studies linked through entity extraction aliases.
Study of Donor Derived, Multi-virus-specific, Cytotoxic T-Lymphocytes for Relapsed/Refractory Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients With High-Risk Neuroblastoma and GD2-Positive Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Protein Expression in Human Neuroblastoma Tumor Samples
- Status
- COMPLETED
- Phase
- N/A
Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma
- Status
- COMPLETED
- Phase
- N/A
NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors
- Status
- UNKNOWN
- Phase
- PHASE3
131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol
- Status
- AVAILABLE
- Phase
- N/A
Biomarkers in Samples From Young Patients With Neuroblastoma
- Status
- COMPLETED
- Phase
- N/A
Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma
- Status
- COMPLETED
- Phase
- NA
Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer
- Status
- COMPLETED
- Phase
- N/A
Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Aflac ST1001 Prolonged Isotretinoin
- Status
- WITHDRAWN
- Phase
- PHASE1
High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)
- Status
- UNKNOWN
- Phase
- NA
Immunomonitoring of Children With Neuroblastoma
- Status
- UNKNOWN
- Phase
- NA
A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1